The PD-1xVEGF dealmaking wave that has captivated Western pharma companies is now surging within China. | Sino Biopharm said it will pay up to $951 million to acquire LaNova Medicines, which has ...

Amazon is investing another $100 million in the AWS Generative AI Innovation Center to help enterprises move from AI experimentation to real-world deployment, with a growing focus on agentic AI.

Both AstraZeneca and MSD have tied lucrative licensing deals for two of LaNova’s oncology assets in recent years.